U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Showing 1 - 10 of 70 results

Status:
US Approved Rx (2010)
First approved in 2002

Class (Stereo):
CHEMICAL (ABSOLUTE)



Atomoxetine is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder. The precise mechanism by which atomoxetine produces its therapeutic effects in Attention-Deficit/Hyperactivity Disorder (ADHD) is unknown, but is thought to be re...
Status:
US Approved Rx (2018)
First approved in 2001

Class (Stereo):
CHEMICAL (ABSOLUTE)



Dexmethylphenidate is the dextrorotary form of methylphenidate. Dexmethylphenidate is marketed under the trade name Focalin. Focalin (dexmethylphenidate hydrochloride) is the d-threo-enantiomer of racemic methylphenidate hydrochloride, which is a 50/...
Status:
US Approved Rx (2023)
First approved in 1986

Class (Stereo):
CHEMICAL (ACHIRAL)



Etiguanfacine, also known as SSP-1871, is an α2-adrenoreceptor agonist.
Status:
US Approved Rx (1987)
First approved in 1974

Class (Stereo):
CHEMICAL (ACHIRAL)



Clonidine is a centrally acting α2 adrenergic agonist and imidazoline receptor agonist used to treat high blood pressure, attention deficit hyperactivity disorder, anxiety disorders, tic disorders, withdrawal (from either alcohol, opioids, or smoking...
Status:
US Approved Rx (2022)
First approved in 1955

Class (Stereo):
CHEMICAL (RACEMIC)



Methylphenidate is a CNS stimulant approved for the treatment of narcolepsy and attention deficit hyperactivity disorder. The drug is believed to bind the dopamine transporter in the presynaptic cell membrane, thereby blocking the reuptake of dopamin...
Status:
US Approved Rx (1943)
First approved in 1943

Class (Stereo):
CHEMICAL (ABSOLUTE)



DL-Methamphetamine (also known as +/- Methamphetamin) is a central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal met...
Status:
US Approved Rx (2023)
First marketed in 1937

Class (Stereo):
CHEMICAL (ABSOLUTE)



Lisdexamfetamine (LDX) is a d-amphetamine (d-AMPH) pro-drug used to treat Attention Deficit and Hyperactivity Disorder (ADHD) and Binge Eating Disorder (BED). After oral administration, lisdexamfetamine dimesylate is rapidly absorbed from the gastroi...
Status:
US Approved Rx (2019)
First marketed in 1931

Class (Stereo):
CHEMICAL (RACEMIC)



Amphetamine is a potent central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, and obesity. Amphetamine was discovered in 1887 and exists as two enantiomers: levoamphetamin...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



Pozanicline is an alpha4-beta2 neuronal nicotinic receptor partial agonist. It had been in phase II clinical trials for the treatment of attention hyperactivity disorder and Alzheimer’s disease. It was tested for the treatment of schizophrenia too. A...
Status:
Investigational

Class (Stereo):
CHEMICAL (ABSOLUTE)



Dasotraline, also known as SEP-225,289, is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI). It has an extended half-life (47-77 hours) that supports the potential for plasma concentrations yielding a continuous therapeutic effect over ...